{"disease":{"id":"actinic-keratosis","name":"Actinic keratosis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":12,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"5-fu","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"5-fu","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"diclofenac","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Voltaren","generic_name":"DICLOFENAC","company_name":"Hisamitsu Pharmaceutical Co., Inc","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tirbanibulin","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Klisyri","generic_name":"TIRBANIBULIN","company_name":"Almirall","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase Lyn","drug_class":"Microtubule Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":"Klisyri works by disrupting the microtubule network, which is essential for cell division."},{"drug_id":"picato","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Picato","company_name":"LEO Pharma","drug_phase":"discontinued","molecular_target":"Protein kinase C alpha type, Protein kinase C epsilon type, Protein kinase C gamma type","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"ingenol-mebutate","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Picato","generic_name":"INGENOL MEBUTATE","company_name":"Leo Labs","drug_phase":"marketed","molecular_target":"Protein kinase C alpha type, Protein kinase C epsilon type, Protein kinase C gamma type","drug_class":"","quality_score":17,"revenue":null,"mechanism":null},{"drug_id":"fluorouracil","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"fluorouracil","company_name":"Extrovis","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"arthrotec","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arthrotec","generic_name":"Diclofenac Sodium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Acid-sensing ion channel 3","drug_class":"diclofenac","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"masoprocol","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Actinex","generic_name":"MASOPROCOL","company_name":"","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"masoprocol","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"aminolevulinic-acid","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levulan","generic_name":"AMINOLEVULINIC ACID","company_name":"Sun Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Optical Imaging Agent","quality_score":70,"revenue":null,"mechanism":"Levulan accumulates in abnormal skin cells, allowing for visualization and treatment."},{"drug_id":"imiquimod","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldara","generic_name":"IMIQUIMOD","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"7,8-dihydro-8-oxoguanine triphosphatase","drug_class":"imiquimod","quality_score":75,"revenue":null,"mechanism":"Aldara works by activating the immune system to recognize and attack abnormal cells."},{"drug_id":"ameluz","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ameluz","company_name":"Sherrif Ibrahim","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"gliolan","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Gliolan","company_name":"Abramson Cancer Center at Penn Medicine","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":12,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02952898","title":"Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Balmoral Medical company","has_results":true},{"nct_id":"NCT04552327","title":"5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":631,"lead_sponsor_name":"Infectopharm Arzneimittel GmbH","has_results":false},{"nct_id":"NCT03115476","title":"A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":563,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT03200912","title":"An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":507,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT01926496","title":"Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":485,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT02120898","title":"A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":467,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT03727074","title":"Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":462,"lead_sponsor_name":"Sol-Gel Technologies, Ltd.","has_results":false},{"nct_id":"NCT02616601","title":"Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":422,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT02549339","title":"Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":383,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT03285490","title":"A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT05741294","title":"A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT03116698","title":"A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Dr. Reddy's Laboratories Limited","has_results":true},{"nct_id":"NCT02838628","title":"Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT03319251","title":"Biomarker Database Registry for Photodynamic Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT00304239","title":"Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT05060237","title":"Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Biofrontera Bioscience GmbH","has_results":true},{"nct_id":"NCT05231044","title":"A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"PharmaEssentia","has_results":false},{"nct_id":"NCT02844777","title":"Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Vidac Pharma","has_results":true},{"nct_id":"NCT03538951","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Vidac Pharma","has_results":true},{"nct_id":"NCT02404389","title":"Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00472459","title":"Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT04140292","title":"Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT06014697","title":"OCT and Invasion in Cutaneous Skin Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT03037541","title":"Cryosurgery and Cream Combination for Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT05699603","title":"Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"University of Arizona","has_results":false},{"nct_id":"NCT07290959","title":"Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"San Salvatore Hospital of L'Aquila","has_results":false},{"nct_id":"NCT02990221","title":"Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT06778434","title":"The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT03731988","title":"Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Dong-A University","has_results":false},{"nct_id":"NCT06319794","title":"Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"TORQUR","has_results":false},{"nct_id":"NCT03805737","title":"Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":false},{"nct_id":"NCT06888362","title":"Trial to Investigate GZ21T in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Genzada Pharmaceuticals USA, Inc.","has_results":true},{"nct_id":"NCT03083470","title":"Study of SOR007 Ointment for Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"DFB Soria, LLC","has_results":true},{"nct_id":"NCT04359823","title":"DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Medical University of South Carolina","has_results":true},{"nct_id":"NCT03210740","title":"Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"AmDerma","has_results":false},{"nct_id":"NCT06027619","title":"Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT05356572","title":"A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Mirka Ltd","has_results":false},{"nct_id":"NCT03508856","title":"Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Skin Laser & Surgery Specialists","has_results":false},{"nct_id":"NCT03122457","title":"Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":true},{"nct_id":"NCT05900258","title":"Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT06648447","title":"Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Thomas Dirschka","has_results":false},{"nct_id":"NCT02866695","title":"Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT07286318","title":"A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Marissa Lobl","has_results":false},{"nct_id":"NCT03643744","title":"Photodynamic Therapy-Induced Immune Modulation: Part III","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Wright State University","has_results":true},{"nct_id":"NCT02984072","title":"Menthol for PDT Pain Relief","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of Dundee","has_results":false},{"nct_id":"NCT04396184","title":"Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Shanghai Dermatology Hospital","has_results":false},{"nct_id":"NCT03110159","title":"DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Medical Dermatology Specialists","has_results":false}],"total":47},"guidelines":[{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"arthrotec","guideline_body":"FDA label","recommendation":"Not specified for this indication.","line_of_therapy":"any","evidence_grade":"not specified","guideline_year":null},{"drug_id":"fluorouracil","guideline_body":"FDA label","recommendation":"Fluorouracil Cream is recommended for the topical treatment of multiple actinic or solar keratoses.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}